View Intellia Therapeutics, Inc. (NTLA) current and estimated P/E ratio data provided by Seeking Alpha.

Begin your TipRanks Premium journey today. Intellia Therapeutics (NTLA) Company Description: Intellia Therapeutics, Inc. engages in the development of gene editing-based therapies. It provides ...

Intellia Therapeutics (NASDAQ:NTLA), a leading genome editing company with a market capitalization of $1.3 billion, is entering a critical phase in its development as it advances multiple clinical ...